发明授权
- 专利标题： COMPOUND FOR TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- 专利标题（中）： 用于治疗α肾上腺素介导的病症的化合物
-
申请号： EP15165926.5申请日： 2009-06-05
-
公开(公告)号： EP2932968B1公开(公告)日： 2018-01-17
- 发明人: Fang, Wenkui K. , Nguyen, Phong X. , Chow, Ken , Heidelbaugh, Todd M. , Gomez, Dario G. , Garst, Michael E. , Sinha, Santosh C. , Gil, Daniel W. , Donello, John E.
- 申请人： ALLERGAN, INC.
- 申请人地址： 2525 Dupont Drive Irvine, CA 92612 US
- 专利权人： ALLERGAN, INC.
- 当前专利权人： ALLERGAN, INC.
- 当前专利权人地址： 2525 Dupont Drive Irvine, CA 92612 US
- 代理机构： Hoffmann Eitle
- 优先权： US59837P 20080609
- 主分类号： A61K31/4168
- IPC分类号： A61K31/4168 ; A61P9/12
摘要：
Described herein are compounds for use in a method of treating a condition or disease in a subject by administering to the subject a pharmaceutical composition containing an effective amount of an ±-adrenergic modulator. The compounds are also useful for alleviating types of pain, both acute and chronic.
公开/授权文献
- EP2932968A1 COMPOUND FOR TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS 公开/授权日：2015-10-21
信息查询
IPC分类:
